During the past decade, Mississippi Baptist Medical Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mississippi Baptist Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "NRG Oncology" with 1 trials sponsored and "Sironax USA, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mississippi Baptist Medical Center" #1 collaborator was "American Heart Association" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Mississippi Baptist Medical Center" are "Acute Kidney Injury (AKI)" (1 trials), "COVID-19 Infection" (1 trials), "Cardiac Arrhythmia" (1 trials), "Corona Virus Infection" (1 trials) and "Endometrial Clear Cell Adenocarcinoma" (1 trials). Many other conditions were trialed in "Mississippi Baptist Medical Center" in a lesser frequency.

Most popular intervention types in "Mississippi Baptist Medical Center" are "Drug" (4 trials), "Other" (2 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Quality-of-Life Assessment" (2 trials), "Questionnaire Administration" (2 trials) and "ASP1128" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mississippi Baptist Medical Center" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Mississippi Baptist Medical Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Mississippi Baptist Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mississippi Baptist Medical Center, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".